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Dissociation of the 10 S androgen  receptor  to 8, 6, 
and 4.5 S forms was dependent on temperature, the 
reducing and ionic environment, and the binding of 
androgen. The [3H]dihydrotestosterone-labeled 10 S 
receptor was observed at low  ionic  strength  using  rat 
Dunning prostate tumor cytosol freshly prepared in 
the  absence  of  an  exogenous  sulfhydryl  reducing age t. 
Addition  of  mercaptoethanol  caused €0 S receptor dis- 
sociation to 8 S following incubation at 0 O C  for 30 
min,  to  6 S after a 30-min incubation at 23 “C at low 
ionic strength, and to 4.5 S at high ionic strength. 
Mercaptoethanol-induced  dissociation  required  bind- 
ing of [SH]dihydrotestosterone. Treatment with cupric 
phenanthroline,  a  disulfide-forming reagent, stabilized 
the 10 S receptor  in 0.4 M KCl, but  the  receptor re- 
mained sensitive to dissociation by mercaptoethanol. 
Zn2+ (25 IIM) and  sodium  molybdate (10 mM) also  st+- 
bilized the 10 S receptor. A Stokes radius of 96 +. 5 A 
was determined  for  the 10 S receptor  by  Sepharose- 
6B chromatography, with a  calculated M, of 396,000. 
The 10 S receptor was not  retained  by  DNA-Sepha- 
rose, while dissociated  forms  displayed  binding affin- 
ity for DNA. It is proposed that the 10 S receptor 
represents  the  nontransformed adrogen receptor, 
composed of the 4.5 S steroid binding units plus a 
nonsteroid binding protein, perhaps in a tetrameric 
configuration.  Binding of dihydrotestosterone  appears 
to sensitize the 10 S receptor  to  disulfide bond reduc- 
tion, resulting in transformation by subunit  dissocia- 
tion. 
The use of sodium molybdate provided the  first clue that 
steroid receptors can  exist as high molecular weight 9-10 S 
complexes (1) that display properties of a nontransformed 
receptor (2,3). Transformation refers to  the process whereby 
steroid receptors acquire high binding affinity for acceptor 
components  in the nucleus. The question has been raised as 
to whether the 10 S form  represents the native  state of steroid 
receptors in  the cell prior to  their transformation (4). One 
possible mechanism of transformation involves dissociation 
of the 10 S complex, resulting in liberation of the 4-5 S steroid 
binding portion of the receptor. Studies on glucocorticoid 
receptor transformation  in  cultured cells support a decrease 
in size from 9.2 S to 4.8 S (5). 
A 9-10 S form of the androgen receptor has been observed 
in  the presence of sodium molybdate (6,7). In the absence of 
molybdate, however, the receptor was previously detected in 
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smaller forms with sedimentation coefficients of 8, 6.2, and 
4.5 S (6). A partial explanation for these various molecular 
forms comes from the identification of a nonsteroid binding 
protein that associates with the 4.5 S high affinity androgen 
binding portion of the receptor. We have partially purified 
this protein, which is referred to  as 8 S androgen receptor- 
promoting factor (8 S-PF)l(S). Based on hydrodynamic meth- 
ods, 8 S-PF has an apparent M, of 170,000. Recent evidence 
suggests that divalent cations, particularly Zn2+ and Ca2+, 
influence whether 8,6.2, or 4.5 S receptor forms predominate 
(6). The progesterone receptor has been reported to contain 
a 90-kDa nonsteroid binding protein (9). Using monoclonal 
antibody probes, the 90-kDa protein was found to be a com- 
mon component of most steroid receptors (10,l l)  and  appears 
to be homologous to  the 90-kDa heat shock protein (11). The 
90-kDa mammalian heat shock protein  is known to dimerize 
to mass 165 kDa (12). 
The fact that detection of  9-10 S forms of steroid receptors 
requires sodium molybdate has cast some doubt on their 
biological significance. For this reason, we set  out to examine 
whether the effect of molybdate could be  mimicked  by other 
reagents and to determine what these receptor-modifying 
reagents might reveal about the process of androgen receptor 
transformation. We have reported previously that some of the 
effects of molybdate are similar to  the effects of Zn2+ on the 
androgen receptor (6). Because sulfhydryl groups are  a known 
site of interaction for molybdate (13-15) and Zn2+ (16), we 
considered the possibility that disulfide bond reduction may 
play a role in receptor transformation.  This hypothesis has 
been strengthened  in the present study through the use of 
cupric phenanthroline,  a reagent known to induce disulfide 
bond formation (17). Evidence is presented that upon binding 
of dihydrotestosterone, the 10 S androgen receptor is altered 
in such a way that disulfide linkages become  accessible to  the 
reducing activity of cytosol. It is proposed that transformation 
of the androgen receptor requires full reduction of sulfhydryl 
groups for dissociation of receptor components and liberation 
of the 4.5 S transformed receptor. 
EXPERIMENTAL PROCEDURES 
Materials 
[1,2,4,5,6,7-3H]Dihydrotestosterone (120 Ci/mmol) was purchased 
from Amersham; diisopropyl fluorophosphate, human fibrinogen, 
equine myoglobin, horse spleen apoferritin, 1,lO-phenanthroline 
monohydrate, calf thymus DNA, cyanogen bromide-activated Seph- 
arose-4B and Trizma base (Tris buffer) from Sigma; bovine 7-glob- 
ulins  (fraction 11) and bovine albumin from Miles; ovalbumin from 
Chemalog; reagent grade chemicals including sodium molybdate, 2- 
mercaptoethanol, and Scintiverse from Fisher. 
‘The abbreviations used are: 8 S-PF, 8 S androgen receptor- 
promoting factor; Pipes, 1,4-piperazinediethanesulfonic acid. 
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Methods 
Animals-Male Copenhagen rats of  -100 g received subcutaneous 
transplantations of the R3327H Dunning  tumor at multiple sites as 
previously described (6). Rats bearing tumors of 1-5 g were  Orchiec- 
tomized through an abdominal incision under ether anesthesia 18-24 
h prior to sacrifice. Rats were killed by decapitation, and tissues were 
rapidly removed and either used immediately or frozen in liquid 
nitrogen and stored at -70  "C. 
Receptor Preparation-Frozen tumor was pulverized and homoge- 
nized in an ice-water bath  as previously described (6) in 4 volumes of 
buffer containing  10% glycerol, 50 mM Tris, pH 7.0. The  pH deter- 
minations were at  4 "C throughout. A cytosol supernatant fraction 
was prepared by centrifuging the homogenate at 100,000 X g,, in a 
Beckman 35 rotor for 75 min at 33,000 rpm. Cytosol was used 
immediately after preparation for the determination of total receptor 
content using a charcoal adsorption assay (18) and for sucrose gra- 
dient analysis. 
Unless specified otherwise, cytosol was incubated with 15 nM [3H] 
dihydrotestosterone for 1 h at  0 "C. Samples were exposed to various 
treatments as described in the text and figure legends. Prior to 
application to sucrose gradients, free and loosely bound [3H]dihydro- 
testosterone was  removed by adsorption onto a pellet of charcoal for 
20 or 30 min at  0 "C as previously described (6). For quantitation of 
receptor, 0.2- or 0.3-ml cytosol samples were assayed using the char- 
coal adsorption assay (18). Receptor concentration of the R3327H 
tumor ranged from 15-150 fmol/mg of cytosol protein, with a mean 
of  -30 fmol/mg of protein. Cytosol protein concentration was 8-12 
mg/ml. Variation in receptor content reflects heterogeneity in the 
tumor as well as different degrees of receptor inactivation during 
preparation. 
In reconstitution experiments, the 4.5 S [3H]dihydrotestosterone- 
labeled receptor was partially purified by chromatography on phos- 
phocellulose as previously described (8, 19). The 8 S-PF was isolated 
from rat serum by precipitation with saturated (NH&S04, followed 
by chromatography on DEAE-Sepharose (6,8).  The fraction obtained 
on elution with 0.22 M KC], 50 mM Tris, pH 7.2, was concentrated 
by lyophilization, resuspended in 50 mM KCl, 10 mM Tris, pH 7.2, 
and dialyzed against this buffer for 2 h a t  4 "C. 
Sucrose Gradient Centrifigation-Sucrose gradients were 2-20% 
(w/v) sucrose when analyzed in a Beckman SW 50.1 rotor, and 5- 
25% sucrose when analyzed in a Sorvall vertical rotor TV865. The 
gradients  contained  in  addition 0.025 M KCI, 10% glycerol, and 50 
mM Tris, pH 7.0 or 7.2. At pH 7.0 sodium molybdate was most 
effective (6), while in the absence of molybdate, slightly lower non- 
specific aggregation was observed at pH 7.2. Results were essentially 
identical a t  either pH 7.0 or 7.2. Cytosol samples were adsorbed to a 
pellet of charcoal as previously described (6) prior to application to 
the gradient. The  internal protein standards ovalbumin (3.6 S) and 
bovine y-globulin (7 S )  were analyzed in each fraction using the 
Lowry protein assay (20) and  we indicated by arrows in the figures. 
Swinging bucket gradients were centrifuged for 17 h at  47,000 rpm at 
0 "C; vertical gradients were centrifuged for 2.5 h a t  60,000 rpm at 
0 "C. Radioactivity in each gradient fraction was determined by 
adding 4 ml of Scintiverse/toluene (1:l) and counting in minivials 
with an efficiency of 38%. The approximate sedimentation coeffi- 
cients of the receptor peak fractions are indicated in parentheses in 
the figures. 
Preparation of DNA-Sepharose-Calf thymus DNA (0.6 g) was 
dissolved in 1 mM EDTA, 10 mM Tris, pH 7.4 (120 ml)  by rotating 
overnight a t  4 "C. Brief sonication was used to enhance solubilization. 
DNA was extracted 2 times each with phenol/chloroform, chloroform 
and  ether  and was precipitated with ethanol as previously described 
(21). CNBr-activated Sepharose-4B was prepared according to the 
specifications of Pharmacia. The washed matrix  (9 g) was combined 
with DNA dissolved in 120 ml of 10 mM potassium phosphate, pH 
8.0, and mixed overnight a t  23 "C. The reacted matrix was washed 
with 1 liter of 10 mM KHzP04,  pH 8, to remove excess ligand. Active 
groups were  blocked with 1 M ethanolamine, pH 8, mixing at 4 "C 
overnight. The resin was washed with potassium phosphate buffer (1 
liter  each of 10 mM and 1 M, pH 8) and high salt (1 M KCl) followed 
by distilled water as previously described (22). The final DNA- 
Sepharose matrix was suspended in 40  ml of 1 mM EDTA, 10 mM 
mercaptoethanol, and 50 mM Tris, pH 7.5, and stored at  4 "C in 
0.04% NaN3. Columns of DNA-Sepharose (0.9 cm X 2 cm) were 
equilibrated in 10% glycerol and 50 mM Tris, pH 7.0, plus 10 mM 
sodium molybdate for the molybdate-containing sample, and 50 mM 
mercaptoethanol for the mercaptoethanol-containing sample. 
Analytical Methods-Samples to be treated with cupric phenan- 
throline received an addition of %O volume of a freshly prepared stock 
solution of 13 mM 1,lO-phenanthroline, 2.5 mM cuS04, 10% glycerol, 
and 50 mM Tris, pH 7.0,  followed  by incubation for 15 min at room 
temperature as previously described (23). In samples treated with 
mercaptoethanol, dialysis was performed for 2 h at 4 "C  while bub- 
bling Nz through the solution to remove mercaptoethanol prior to 
oxidation with cupric phenanthroline. The method of Lowry et al. 
(20) was used to determine protein  concentration using bovine serum 
albumin as standard. 
Sepharose-GB Chromatography-Sepharose-6B columns (1.6 X 67 
cm)  were equilibrated in 10% glycerol, 0.05 M KCl, 50 mM Tris, pH 
7.0, for the 10 s receptor, and in the same buffer plus 10 mM 
mercaptoethanol and 200 PM ZnClz for analysis of the 8 S receptor. 
Calibration markers included human ebrinogen (fraction I, type?) 
(110 A), horse spleen apoferritin (61 A), bovine y-globulin (52 A), 
and equine skeletal muscle  myoglobin (type I) (19 8). Fractions of 2 
ml  were collected, and radioactivity was determined in 0.5-ml aliquots 
using 4 ml of Scintiverse/toluene as described above. Peak fractions 
were analyzed in sucrose gradients  containing 10% glycerol,  25 mM 
KCl, 50 mM Tris, pH 7.0, as described above. Stokes radii and 
molecular weights were calculated as previously described (24,  25). 
RESULTS 
Znfluence of Mercaptoethanol on Receptor Sedimentation- 
The sedimentation properties of steroid receptors are usually 
determined in sucrose gradients with reducing conditions 
equivalent to about 10 mM mercaptoethanol. The wide use of 
sulfhydryl-reducing agents in studies on steroid receptors 
stems from their  enhancement of steroid binding activity, as 
shown by Pratt and co-workers (26) in  their  studies on the 
glucocorticoid receptor. In  the presence of 10 mM mercapto- 
ethanol under low ionic strength conditions, the androgen 
receptor displayed its classical sedimentation of 7.5-8 S (Fig. 
U), as previously reported (6). Omission of mercaptoethanol 
from sample and gradient buffers resulted in androgen recep- 
tor sedimentation at 10 k 0.5 S (Fig. 1A). The 10 S form 
displayed somewhat lower binding of [3H]dihydr~te~to~ter~ne 
probably due to  the absence of the sulfhydryl-reducing agent. 
Demonstration of the 10 S receptor in  the absence of mercap- 
toethanol required the use of freshly prepared cytosol from 
tissue that was rapidly frozen in liquid Nz and stored at 
-70 "C. In some experiments (Fig. 2), the use of rapid sucrose 
gradient centrifugation (2.5 h) in a vertical rotor was also 
required. Analysis of the same sample shown in Fig. 2 by 
centrifugation in  a swinging bucket rotor for 17 h resulted in 
conversion of the 10 S receptor to  the 8 S form (not shown). 
Other  determinants of receptor size were pH  and  the re- 
ducing environment. At pH 6.8 to 7.2, the 10 S receptor 
complex was relatively stable. However, as the pH of the 
sample and gradient was raised above 7.2, the receptor sedi- 
mented as a broader peak with a maximum between 6.5 and 
8.5 S (not shown). Exposure of cytosol to increased tempera- 
ture (23 "C for 30 min)  in the presence of 10 mM mercapto- 
ethanol converted the [3H]dihydrotestosterone-labeled recep- 
tor  to a smaller form sedimenting at 6.2 0.3 S (referred to 
as  the 6 S form; Fig. lA). Warming to 23 "C for 30 min in  the 
presence of mercaptoethanol and a buffer less sensitive to 
temperature-induced pH changes (10 mM Pipes) produced a 
similar result. In  the absence of mercaptoethanol a t  23 "C for 
30 min, the receptor remained predominantly 10 S (not 
shown). 
The androgen receptor can therefore be  observed as  a 10 s 
complex  when precautions  are  taken to use freshly prepared 
cytosol at pH 6.8-7.2 and  to avoid reducing conditions. The 
10 S receptor in cytosol at 0 "C is susceptible to conversion 
to  an 8 S complex, even in the absence of added reducing 
agent, especially during prolonged centrifugation (17 h) at 
0 "C. One interpretation of these  data is that cytosol contains 
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FIG. 1. Effect of  mercaptoethanol  and  heat  on  receptor sedi- 
mentation  in  the  absence  and  presence  of  sodium  molybdate. 
Freshly prepared tumor cytosol was incubated with 15 nM 13H] 
dihydrotestosterone for 1 h at 0 "C. To cytosol samples in A and B, 
mercaptoethanol was added to 10 mM prior to incubation for 30 min 
at  23 "C (A) or 0 "C (0). Control samples in A and B received no 
mercaptoethanol and were not heated (0). Following these treat- 
ments, samples either received no further additions (A) or sodium 
molybdate was added to 10 mM ( B ) .  Excess free steroid was removed 
by charcoal adsorption. Sucrose gradients  contained the same mer- 
captoethanol and sodium molybdate concentrations as  the sample, 
plus 10% glycerol, 25 mM KC1, 50 mM Tris,  pH 7.0. Sedimentation 
markers are indicated for 7-globulin (7 S) and ovalbumin (3.6 S). 
The approximate  sedimentation coefficients for receptor forms are 
indicated in parentheses. The peak at 4.6 S represents nonspecific 
binding to albumin present in  the cytosol. 
endogenous reducing agents that  act during prolonged cen- 
trifugation to convert the 10 S [3H]dihydrotestosterone-la- 
beled receptor to  an 8 S form. 
Effects of Sodium Molybdate-Receptor sedimentation was 
also investigated in sucrose gradients  containing 10 mM so- 
dium molybdate (Fig. lB), a reagent shown previously to 
stabilize not only steroid receptor binding sites (26-28), but 
also the large form of steroid receptors (1, 6). As shown in 
Fig. lB,  the androgen receptor sediments predominantly at 
10 S in a gradient  containing 10 mM molybdate, 0.025 M KC1, 
10% glycerol, 50 mM Tris, pH 7.0, without mercaptoethanol. 
Thus, when freshly prepared cytosol is analyzed in  the absence 
of a sulfhydryl-reducing agent, sedimentation of the androgen 
receptor is essentially the same in  the presence or absence of 
molybdate. However, molybdate clearly stabilizes the 10 S 
receptor, especially during long term centrifugation in sucrose 
gradients, and enhances androgen receptor binding activity 
(Fig. 1, A and B ) .  
The effect of mercaptoethanol on receptor sedimentation 
was investigated before and after the addition of sodium 
molybdate. When 10 mM molybdate was added prior to  the 
addition of mercaptoethanol, the receptor sedimented as 9.2 
& 0.3 S (Fig. lB), as opposed to 8 S in the absence of 
molybdate (Fig. lA). This 9 S form of the receptor was stable 
in molybdate-containing cytosol even when the sample was 
heated for 30 min at 23 "C in  the presence of mercaptoethanol 
concentrations as high as 200 mM. However, exposure to 
mercaptoethanol  prior to  the addition of molybdate caused 
dissociation to  the 6 S form, even when assayed in sucrose 
gradients  containing molybdate (Fig. 1B). In  the absence of 
of the 10 S Androgen Receptor 6503 




FIG. 2. Vertical  rotor  analysis of the receptor from fresh 
tumor at  increasing  salt  concentrations. An R3327H tumor was 
rapidly removed and homogenized in  the absence of mercaptoethanol 
as described under "Methods." Cytosol was labeled with 15 nM [3H] 
dihydrotestosterone for 1 h at  0 "C. KC1 was added to 25 mM (O), 
0.15 M (0), or 0.4 M (A). Free  steroid was removed by treatment with 
charcoal, and samples (0.24 ml) were analyzed in 5-25% linear sucrose 
gradients containing the same salt concentration as  the sample plus 
10% glycerol, 50 mM Tris,  pH 7.2. Vertical rotor centrifugation was 
for 2.5 h at 60,000 rpm. Approximate sedimentation coefficients are 
indicated in parentheses and  the sedimentation of marker  proteins is 
indicated by arrows for ovalbumin (3.6 S) and y-globulin (7 S). 
Nonspecific binding to albumin accounted for less than 10% of the 
total counts  in the 4.5 S region of the gradient. 
molybdate, a concentration of 1 mM mercaptoethanol con- 
verted 80% of the receptor to  the 6 S form, as estimated by 
the radioactivity in  the 6 and 10 S peaks of a molybdate- 
containing sucrose gradient. A mercaptoethanol concentra- 
tion of 200 mM at 23  "C for 30 min caused complete conversion 
to  the 6 S form. Thus, the 6 S receptor form obtained upon 
addition of mercaptoethanol to cytosol in the absence of 
molybdate cannot be converted back to 10 S by the subsequent 
addition of molybdate (Fig. IB) .  
These results indicate that prior exposure to molybdate 
protects the large form of the receptor from the dissociating 
effect of mercaptoethanol. In a similar way, molybdate likely 
protects the 10 S receptor from the dissociating effects of 
endogenous reducing agents. Based on  the known ability of 
molybdate to interact with sulfhydryl groups (13-151, molyb- 
date may inhibit reduction of disulfide bonds, as discussed 
below. Alternatively, it may act to bridge nearby sulfhydryl 
groups (13, 15). A similar mechanism for molybdate action on 
the progesterone receptor has been proposed (29). 
Effects of Salt on Receptor Sedimentation in the Absence of 
Exogenous Reducing Agents-A long  recognized property of 
large steroid receptor complexes is the susceptibility of their 
component proteins to dissociation at salt  concentrations of 
0.15 M or higher. We investigated whether reducing agents 
enhance the dissociating effect of salt. As shown in Fig. 2 
using rapid vertical rotor analysis in  the absence of mercap- 
toethanol, approximately one-third of the receptor sedi- 
mented at 10 S in 0.15 M KC1, 50 mM Tris, pH 7.2. The 
proportion of 10 S versus 4.5 S receptor assayed in 0.15 M 
KC1 varies with the preparation, ranging from 5-45%  of the 
total receptor in the gradient. In 0.4 M KCI, 50 mM Tris, pH 
7.2, the receptor was predominantly 4.7 k 0.3 S (referred to 
as  the 4.5 S form) (Fig. 2). In  the presence of mercaptoethanol, 
larger forms of the receptor displayed no resistance to disso- 
ciation in 0.15 M KCI,  50 mM Tris,  pH 7.2, and were converted 
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completely to  the 4.5 S form as previously reported (24) (data 
not shown). Thus, reducing agents  enhance salt-induced dis- 
sociation of the androgen receptor. These observations on salt 
dissociation of the native  10 S receptor raise the possibility 
that salt promotes a conformational change that exposes 
disulfide bond(s) to  the reducing activity of cytosol. 
Influence of fHJDihydrotestosterone Binding on  Receptor 
Sensitivity to Reduction-The possibility that binding of [3H] 
dihydrotestosterone might alter receptor sensitivity to reduc- 
tion was investigated by  testing  the effectiveness of mercap- 
toethanol in converting the 10 S receptor to  the 6 S form 
before and  after labeling with [3H]dihydrotestosterone. For 
this experiment, cytosol preparations with relatively high 
receptor content were required because androgen binding 
activity of the unoccupied receptor is susceptible to inactiva- 
tion at increased temperature (18). The mechanism of inac- 
tivation is unknown, although binding activity of the unoc- 
cupied glucocorticoid receptor is believed to be markedly 
increased by sulfhydryl-reducing agents (26). Receptor in 
cytosol, either unlabeled or labeled with [3H]dihydrotestos- 
terone, was exposed to 10 mM mercaptoethanol for 30 min at 
23  "C. The unlabeled receptor treated with mercaptoethanol 
was then incubated at 0 "C in  the presence of 15 nM [3H] 
dihydrotestosterone. Due to  the lability of the 10 S form and 
the steroid binding site, sodium molybdate was added to  the 
sample after  treatment  with or without mercaptoethanol and 
to  the sucrose gradients. As shown above, the sedimentation 
of the 6 S receptor obtained by exposure to mercaptoethanol 
is unaffected by the subsequent addition of sodium molybdate 
(see Fig. 1). 
As shown in Fig.  3, the 10 S receptor (shown by the open 
circles) exhibited the expected decrease in binding activity 
following exposure in  its unlabeled form to mercaptoethanol 
for 30 min at 23 "C  plus 17 h at 0 "C in  its labeled form during 
gradient centrifugation in  the presence of molybdate. More 
importantly, however, there was a striking absence of the 6 S 
form of the receptor. This  is  in  contrast  to  the appearance of 
the 6 S receptor after mercaptoethanol treatment of the 10 S 
[3H]dihydrotestosterone-labeled receptor (Fig. 3, solid trian- 
gles). The lack of 6 S receptor following exposure of unlabeled 
receptor to mercaptoethanol was probably not due to loss of 
binding activity, although the possibility of preferential  in- 
activation of the 6 S receptor steroid binding site  cannot be 
ruled out. Additional experiments with smaller decreases in 
10 S binding activity also did not reveal a 6 S receptor form. 
As noted above in a control experiment, exposure to 23 "C for 
30 min in  the absence of mercaptoethanol  did not significantly 
alter  the sedimentation of the steroid-bound 10 S receptor 
(not shown). Thus, binding of dihydrotestosterone appears 
not only to stabilize the androgen binding site on the 10 S 
receptor, but also to sensitize the receptor to  the dissociating 
effect of reducing agents. 
Disulfide Bond Formation Induced by Cupric Phenanthro- 
line-In order to obtain more direct evidence for a possible 
role of disulfide bond formation  in stabilization of the 10 S 
receptor, we have used the sulfhydryl group-specific  oxidizing 
reagent cupric phenanthroline. This reagent could not be used 
in studies with the unoccupied receptor since exposure at 
room temperature for 15 min caused loss of steroid-binding 
activity. This was due in part to the heat lability of the 
steroid-free receptor, as well as  the requirement of sulfhydryl 
groups for binding activity (30). In  contrast, cupric phenan- 
throline did not cause loss of binding activity of the [3H] 
dihydrotestosterone-labeled receptor. Classical sulfhydryl- 



















FIG. 3. Sensitization to reduction by receptor binding of 
[3H]dihydrotestoste. A fresh cytosol preparation with rela- 
tively high receptor content (150 fmol/mg of protein) was incubated 
with 10 mM mercaptoethanol for 30 min at 23 "C either prior to 
labeling (0) or  after labeling (A) with [3H]dihydrotestosterone ([3H] 
DHT) for 1 h at 0 "C. A control sample received no mercaptoethanol, 
was not heated (O), but was incubated for 1 h at 0 "C with [3H] 
dihydrotestosterone. Following incubation and labeling with [3H] 
dihydrotestosterone with no further additions of mercaptoethanol, all 
samples received the addition of sodium molybdate to 10 mM and 
were treated with charcoal to remove excess steroid. Gradients were 
analyzed in the SW 50.1 rotor and contained the same mercaptoeth- 
an01 concentration as  the sample, plus 10% glycerol, 25 mM KCl, 10 
mM sodium molybdate, 50 mM Tris, pH 7.0. Sedimentation  markers 
are indicated for ovalbumin (3.6 S) and y-globulin (7 S). 
binding activity of both occupied and unoccupied androgen 
receptors. 
Following exposure of the [3H]dihydrotestosterone-labeled 
receptor in cytosol to cupric phenanthroline for 15 min at 
room temperature, receptor was analyzed in sucrose gradients 
under varying conditions. At low ionic strength (0.025 M KC1 
and 50 mM Tris), the cupric phenanthroline-treated receptor 
sedimented at 10 S (Fig. 4A). This was identical to the 
sedimentation behavior of the native or molybdate-stabilized 
10 S form observed in  the absence of mercaptoethanol (see 
Fig. 1). Without cupric phenanthroline  treatment, the recep- 
tor displayed its characteristic 8 S form when analyzed in  the 
presence of mercaptoethanol (Fig. 4A). The cupric phenan- 
throline-treated sample remained 10 j, 0.5 S when analyzed 
in gradients containing 0.15 M KCl, 50 mM Tris, pH 7.2. This 
contrasts to  the 5 S receptor (referred to  as 4.5 S) observed 
at this salt concentration  in the presence of 10 mM mercap- 
toethanol without prior  treatment with cupric phenanthroline 
(Fig. 4B). Even 0.4 M KC1 was ineffective in disrupting the 
cupric phenanthroline-treated 10 S receptor (Fig. 4C). Thus, 
treatment with a reagent known to potentiate disulfide bond 
formation (17) and prevent  disruption of disulfide bonds by 
endogenous reducing agents  results in stabilization of the 10 
S form at elevated salt concentrations. If the  salt concentra- 
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FIG. 4. Salt  stability of the 10 S receptor following  treat- 
ment with cupric  phenanthroline. Cytosol labeled with [3H]di- 
hydrotestosterone was incubated in  the presence (0) or absence (0) 
of 0.25 mM cus04,  1.3 mM 1,lO-phenanthroline, 10%  glycerol, 50 mM 
Tris,  pH 7.0, for 15 min at  23 "C. Mercaptoethanol was added to a 
final  concentration of 10 mM to samples that were not  treated with 
cupric phenanthroline. All samples received the addition of salt  to 
0.025 M KC1 ( A ) ,  0.15 M KC1 ( B )  or 0.4 M KC1 (C) following the 
oxidation reaction or addition of mercaptoethanol. Excess free steroid 
was removed by charcoal adsorption. Samples were analyzed in  an 
SW 50.1 rotor in gradients  containing the same salt  and mercapto- 
ethanol concentration as  the sample, plus 10% glycerol, 50 mM Tris, 
pH 7.2. Sedimentation  markers are indicated for ovalbumin (3.6 S) 
and y-globulin (7 S). 
tion of cytosol containing [3H]dihydrotestosterone-labeled re- 
ceptor was raised to 0.4 M KC1 prior to exposure with cupric 
phenanthroline, the receptor sedimented as 4.5 S in 0.4 M 
KC1 (data  not shown). 
The reversibility of cupric phenanthroline oxidation of 
disulfide bonds in  the 10 S androgen receptor complex was 
tested by observing the effect of mercaptoethanol on the 
cupric phenanthroline-treated receptor. As shown in Fig. 5, 
the cupric phenanthroline-treated 10 S receptor was con- 
verted to  the 6 S form following a 30-min exposure to 10 mM 
mercaptoethanol a t  23 "C. This 6 S receptor was indistin- 
guishable from the 6 S form of the receptor described above. 
Thus,  the cupric phenanthroline-stabilized 10 S receptor re- 
sembles the native receptor in its sensitivity to reducing 
agents, but displays greater resistance to salt dissociation. 
These data are  consistent  with the hypothesis that disulfide 
bond reduction results  in receptor dissociation. 
After reduction of disulfide bonds with mercaptoethanol at 
0 or 23  "C, treatment with cupric phenanthroline was usually 
ineffective in restoring the 10 S receptor complex. Thus, 
receptor conversion from 10 to 8, 6, or 4.5 S forms appeared 
to be irreversible under the conditions used in  this study. A 
likely explanation for this  apparent lack of reversibility is 
that  the sulfhydryl groups involved in 10 S receptor stabili- 
zation are  in an altered configuration once receptor dissocia- 
tion  has occurred. 
Ventral Prostate Androgen Receptor-In order to ascertain 
that  the behavior of the receptor noted above is  not unique to 
the R3327H Dunning tumor, we repeated several crucial 
experiments using rat ventral  prostate cytosol. In general, it 
is difficult to study the ventral  prostate receptor due to  the 
high level of protease activity resistant to inhibition by diiso- 
propyl fluorophosphate (18). By using fresh cytosol and a 1- 
h labeling time with [3H]dihydrotestosterone at 0 "C, prote- 
olysis could be minimized. As shown in Fig. 6, the receptor in 
untreated cytosol sedimented as 7.5 S. Using rapid vertical 
rotor (not shown) or long term swinging bucket rotor  centrif- 
ugation (Fig. 6), the 10 S receptor was not observed in fresh 
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FIG. 5. Reduction of the cupric phenanthroline-treated 10 
S receptor  by  mercaptoethanol. Freshly prepared cytosol labeled 
with 15 nM [3H]dihydrotestosterone was treated for 15 min at room 
temperature with 0.25 mM CuSO,, 1.3 mM 1,lO-phenanthroline, 50 
mM Tris, pH 7.0 (0,O). To one-half of the sample, mercaptoethanol 
was added to 10 mM, and  the cytosol was heated for 20 min at room 
temperature (0). A control sample labeled in the presence of a 100- 
fold excess unlabeled dihydrotestosterone was treated similarly with 
cupric phenanthroline, followed  by exposure to 10 mM mercaptoeth- 
anol for 20 min at  room temperature (A). Samples were treated with 
charcoal to remove unbound steroid and analyzed in an SW 50.1 
rotor  in gradients containing 0.025 M KC1, 10% glycerol, 50 mM Tris, 
pH 7.2, in  the presence (0, A) or absence (0) of 10 mM mercaptoeth- 
anol. Sedimentation  markers  are indicated for ovalbumin (3.6 S) and 
7-globulin (7 S). 
cupric phenanthroline or 10 mM sodium molybdate stabilized 
the 10 S receptor in  ventral  prostate (Fig. 6). These observa- 
tions  indicate that  the ventral  prostate receptor behaves in a 
manner similar to the Dunning tumor androgen receptor, 
although there appears to be higher endogenous reducing 
activity in  ventral  prostate cytosol. 
Effects of Ca2+ and Zn2+ on  Receptor  Sedimentation--\?'e 
have observed previously (6) that Ca2+ causes dissociation of 
the 8 S receptor to  the 4.5 S form. It was therefore of interest 
to determine whether Ca2+ could similarly disrupt the 10 S 
receptor. Ca2+ (3 mM) was only minimally effective in dis- 
rupting the native 10 S receptor observed in cytosol in the 
absence of added reducing agent  and did not  alter the 10 S 
receptor obtained following treatment with cupric phenan- 
throline  (data  not shown). Thus, unlike its dissociating effect 
on the 8 S receptor, calcium could not disrupt the 10 S 
receptor. The dissociating influence of Ca2+ appears to re- 
quire, therefore, prior conversion of the 10 S receptor complex 
to 8 S. 
Zinc interacts with metalloproteins through  either sulfhy- 
dryl groups of cysteine or with histidine, which curiously are 
also known sites of interaction of sodium molybdate with 
proteins (15). Our previous studies have shown that Zn2+ 
enhances the interaction of 8 S-PF,  the nonsteroid binding 
protein of the 8 S androgen receptor, with the 4.5 S steroid 
binding receptor to generate the 8 S form (6). Since these  and 
other  studies were carried out  in the presence of mercaptoeth- 
anol (31), we investigated the effect of Zn2+ on receptor 
sedimentation  in the absence of mercaptoethanol. 











FIG. 6. Stabilization of the 10 S androgen receptor in  rat 
ventral prostate. Frozen  ventral  prostates  from  Copenhagen rats 
castrated 18 h prior to sacrifice  were  homogenized  as  described  under 
“Methods” in buffer containing 10% glycerol, 2 mM diisopropyl 
fluorophosphate,  and 50 mM Tris, pH 7.0. Cytosol  was  incubated  with 
15 nM [3H]dihydrotestosterone  for 1 h at 0 “C. In  addition, a sample 
(0) was incubated  in the presence of [3H]dihydrotestosterone  plus a 
100-fold  excess of unlabeled  dihydrotestosterone to control  for  non- 
specific binding to albumin and prostatein. The samples were ali- 
quoted into 0.35 ml  and either were  not further  treated (0) or  were 
incubated  with  cupric  phenanthroline  (see  “Methods”) at 23 “C for 
15 min (A), 10 mM sodium  molybdate at 0 “C (A), or 25 p M  ZnCL at 
0 “C (17). Samples  were treated with  charcoal to remove  excess  free 
steroid and analyzed on 5-25% sucrose gradients containing 10% 
glycerol, 25 mM KCl, 50 mM Tris, pH 7.0, plus 10 mM sodium 
molybdate  for the sample  containing  molybdate, or plus 25 p M  ZnC4 
for the sample  containing  ZnZ+.  Gradients  were  centrifuged for 19.5 
h at 47,000 rpm  in a SW 50.1 rotor at 0 “C. 
Zinc at  a concentration of 15-25 p~ in the absence of 
mercaptoethanol stabilized receptor  sedimentation in  the 10 
S form in Dunning tumor cytosol (not shown) and  in  ventral 
prostate (Fig. 6). Chromatography of cytosol through  Sepha- 
dex G-25 in Zn2+-free buffer caused the receptor to sediment 
as 8 S. Addition of Zn2+ (25 p ~ )  to  the column flow-through 
fraction restored the 10 S form. Thus, Zn2+, like sodium 
molybdate, stabilizes the 10 S androgen  receptor in the  ab- 
sence of mercaptoethanol. Although molybdate cannot be an 
endogenous component of the 10 S receptor, it is not  unrea- 
sonable to suggest that Zn2+ might  be part of the native 10 S 
androgen receptor complex. Zinc, acting as a bridge between 
sulfhydryl groups, might provide a flexible linkage that detects 
a change in receptor  conformation induced by steroid binding, 
as postulated above. 
Receptor Binding to DNA-Sepharose-The ability of steroid 
receptors to bind DNA has been considered a criterion for 
receptor transformation. We have therefore compared the 
DNA binding of the stabilized 10 S receptor in cytosol relative 
to the unstabilized receptor and  to  the fully reduced receptor. 
The same amount of cytosol treated in various ways was 
chromatographed on DNA-Sepharose. As shown in  Table I, 
10 S receptor forms stabilized by sodium molybdate or cupric 
phenanthroline were retained poorly by DNA-Sepharose. In 
contrast, approximately one-half of the fully reduced receptor 
was bound to DNA, In  the absence of 10 S stabilizing agents 
TABLE I
DNA-Sepharose binding of the androgen  receptor 
Freshly  prepared tumor cytosol (4.5 ml/column)  was  labeled  for 1 
h with 15 nM [3H]dihydrotestosterone, followed by either no  addition 
or treatment with  sodium  molybdate (10 mM),  cupric  phenanthroline 
(see “Methods”), or mercaptoethanol (50 mM). All samples were 
incubated for 15 min at 23 “C  prior  to  removal of excess  steroid  by 
charcoal adsorption. Following sample application, DNA columns 
were  washed  in  equilibration  buffer,  and  the  receptor  was  step-eluted 
with 0.3 M KC1 in  the  equilibration  buffer.  Total  receptor  present  in 
cytosol was determined using the charcoal adsorption assay. The 
extent of receptor binding to DNA-Sepharose is exuressed as the 
percentage of total receptor  applied to the column that was eluted 
with 0.3 M KC1. 
Treatment 
fmol % 
No  addition 545 30 
Sodium  molybdate 892 5 
Cupric  phenanthroline 537 7 
Mercaptoethanol 597 49 
and mercaptoethanol, 30% of added receptor bound to DNA 
(Table I), probably due to  the action of endogenous reducing 
agents that convert the 10 S receptor to smaller forms. The 
low apparent binding  affinity of the 10 S androgen receptor 
for DNA supports the concept that 10 S steroid receptors are 
nontransformed (4). In addition, it appears that fully reduced 
free sulfhydryl groups enhance receptor binding to DNA, as 
reported for the glucocorticoid (32,33) and progesterone (34) 
receptors. In previous experiments, we did not detect a form 
of the androgen receptor in Dunning  tumor or ventral  prostate 
cytosol that displayed negligible binding to DNA. This was 
probably due to  the activity of endogenous sulfhydryl reducing 
agents in cytosol, in addition to  the use of mercaptoethanol, 
both of which act  to dissociate the 10 S receptor and expose 
Molecular Weight Determination of the 10 and 8 S Recep- 
tors-Hydrodynamic methods were used to estimate the mo- 
lecular weight of the 10 S androgen receptor. Cytosol was 
labeled with [3H]dihydrotestosterone and  treated with cupric 
phenanthroline as described. The receptor was partially  pu- 
rified using 50% saturated (NJ3J2SO4, a procedure that did 
not  alter  the 10 S sedimentation. One ml of a 10-fold concen- 
trated sample was chromatographed throuJh Sepharose-GB 
as shown in Fig.  7. A Stokes radius of 96 +. 5 A was determined. 
The peak column fraction was analyzed by sucrose gradient 
centrifugation, and a sedimentation coefficient of 10 S was 
obtained. These hydrodynamic parameters were used in 
standard equations (24, 25) to estimate an M, of 396,000 k 
20,000 for the 10 S, 96 receptor (Table 11). 
For comparison, the Stokes  radius of the 8 S receptor was 
determined  on the same column equilibrated in 10% glycerol, 
50 mM KCl, 10 mM mercaptoethanol, 200 pM ZnC12, 50 mM 
Tris,  pH 7.0. A reconstituted 8 S receptor was prepared by 
combining the 4.5 S receptor partially purified by phospho- 
cellulose chromatography  with a fraction  containing 8 S-PF 
(8), as described under ‘’Metho0ds.” The peak fraction  eluted 
with a-Stokes radius of 82 +- 3 A (Fig.  7) and sedimented at 8 
S in a sucrose gradient (not shown). A M, of 270,000 was 
determined for the 8 S receptor (Table 11). Based on the 
similar behavior of the reconstituted and cytosol 8 S receptors 
(6), they may share similar molecular dimensions; it is possi- 
ble,  however, that cytosol 8 S receptor differs slightly. 
sulfhydryl groups. 
DISCUSSION 
Data presented in  this report suggest that disulfide bond 
reduction of the 10 S receptor complex plays a role in  the 
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FIG. 7. Sepharose-GB chromatography of the 10 and 8 S 
receptors. For preparation of the 10 S receptor (O), tumor cytosol 
(10 ml) was labeled with 15 nM [3H]dihydrotestosterone for 1 h at  
0 “C. Cupric phenanthroline was added and incubated as described 
under “Methods.” An equal volume of saturated (NH&S04 in 50 mM 
Tris,  pH 7.0, was added dropwise with stirring. After 20 min at 0 “C, 
the precipitate was pelleted, resuspended in 0.7 ml of 10%  glycerol, 
50 mM KC1,50 mM Tris,  pH 7.0, and dialyzed against the same buffer 
for 1.5  h at 0 “C. The sample was treated with a pellet of charcoal to 
remove excess free steroid and applied to a Sepharose-GB column (1.6 
X 67 cm) equilibrated in  the same buffer. For preparation of the 8 S 
receptor (0), the partially purified 4.5 S [3H]dihydrotestosterone- 
labeled receptor from phosphocellulose (see “Methods”) was com- 
bined with partially purified 8 S-PF and dialyzed against a buffer 
containing 10%  glycerol, 50 mM KCI, 10 mM mercaptoethanol, 200 
~ L M  ZnClz, 50 mM Tris,  pH 7.0, for 2  h a t  0 “C. The sample was applied 
to a Sepharose-GB column equilibrated in the same buffer. Fractions 
of 2  ml were collecte$ with a flow rate qf  -10 ml/h. Elution  positions 
for fibrinogen (110 A), apoferritin  (61 A), 7-globulin (52 A), myoglo- 
bin (19 A), and  the void volume (V,) are indicated with arrows. The 
correlation coefficient of least  squares analysis was -1. 
TABLE 11
Hydrodynamic properties of the different molecular forms 
of the androgen receptor 
The hydrodynamic parameters of the various forms of the androgen 
receptor were determined using sucrose gradient centrifugation and 
gel filtration chromatography. The gel filtration columns were Seph- 
arose-6B for the 10 and 8 S forms as described under “Methods.” The 
hydrodynamic properties of the 6 and 4.5 S forms of the receptor 
were reported previously (6, 24). Molecular weights were estimated 
as previously described (24,251. 
Sedimentation Stokes Molecular 
coefficient radius weight 
S A 
10.0 f 0.5 96 f 5 396,000 
8.0 f 0.4 82 f 3 270,000 
6.2 f 0.3 73 -c 5 203,000 
4.7 f 0.3 58 +. 3 117,000 
mechanism of androgen receptor transformation. The  data 
support the hypothesis that dihydrotestosterone binding to a 
10 S androgen receptor results in sensitization of one or more 
disulfide bonds to reduction. Subsequent dissociation of the 
10 S complex leads to acquisition of DNA binding activity, a 
hallmark of the transformed state of steroid receptors. On the 
other hand, the data do not rule out the possibility that 
oxidation with cupric phenanthroline creates new disulfide 
bonds not  present  in the native molecule. The 10 S receptor 
may contain two closely positioned sulfhydryl groups that can 
be converted to a disulfide linkage by cupric phenanthroline 
or form a stabilizing bridge with sodium molybdate or zinc 
(see below). 
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Molecular weight considerations indicate that the 10 S 
receptor may reprpent a tetramer of a& configuration, where 
a is the 4.5 S, 58 A, MI 117,000 high affinity androgen binding 
receptor (24), and Pz reprfsents 8 S androgen receptor-pro- 
moting factor (-6.5 S, 58 A, MI -170,000) (8). This model is 
speculative because the subunit composition of 8 S-PF has 
not been directly determined. In support of the model is  the 
fact that the predicted molecular weight of the tetramer 
(404,000) is close to  the calculated MI 396,000 for the 10 S, 
96 A receptor. Hydrodynamic veasurements indicate that 
conversion from 10 to 8 S (82 A, M, 270,000) represents a 
decrease in molecular size of 126,000. One could speculate 
that 10 to 8 S conversion results in release of one 4.5 S 
receptor unit. This freed steroid binding protein could asso- 
ciate with the nonsteroid binding protGn to form another 8 S 
receptor. Conversion to  the 6.2 S, 73 A, M, 203,000 receptor 
might result from dissociation of one subunit of 8 S-PF, as 
proposed previously (6). The location and number of putative 
disulfide bonds within the proposed tetrameric  structure  has 
not been determined, dthough  the  data suggest  possible link- 
ages between the 4.5 S steroid binding subunits or between 
the subunits of 8 S-PF.  Other conceivable  models of the 10 S 
receptor not specifically addressed by these  studies  are that  it 
may be the 4.5 S receptor associated with one or several other 
macromolecules which may or may not include 8 S-PF (11, 
35-37), or it may be a multimer of the steroid binding subunit 
of the receptor, as recently reviewed (4). 
The mechanism of molybdate inhibition of steroid receptor 
transformation has remained unclear. Although it was ini- 
tially thought to  act by inhibiting  phosphatase activity (26), 
more recent evidence supports a direct interaction with the 
receptor (2, 29). From studies reported here, molybdate ap- 
pears to stabilize the 10 S androgen receptor by blocking the 
action of endogenous and exogenous reducing agents. This 
hypothesis is supported by the fact that molybdate interacts 
to form bridge structures between adjacent sulfhydryl groups 
(13, 15) as shown below. Alternatively, molybdate might sta- 
bilize a preexisting disulfide bond by forming a coordination 
complex, or by acting as a mild  oxidizing agent to promote 
disulfide bond formation (14).  Zinc interacts with sulfhydryl 
groups and can form disulfide complexes,  while cupric phen- 
anthroline induces covalent, salt-stable disulfide bonds as 
shown below. 
Sulfhydryls linked by 
C H z S  0 0 0 S-CH2 
Mo Mo, 0 sodium molybdate 
II (13) 
R~-c--CIH-NH  OH^ o  OH^ NH-CH-c 
I I / 
R1 Rz Rz 
R1-S-Zn-S-& zinc (16) 
R1”S-S-R2 cupric phenanthro- 
line (17) 
Sulfhydryl groups are known to be important not only for 
receptor steroid binding activity (30), but also for receptor 
binding to DNA and  in receptor transformation (32-34,  38). 
Sulfhydryl groups in  the glucocorticoid receptor have been 
implicated in receptor subunit  interactions (38). 
An almost universal requirement for in vitro steroid recep- 
tor transformation  has been exposure of the steroid-bound 
receptor to  an increase in temperature (-25 “C) for a short 
period (39,  40). The mechanism of this  heat activation step 
has remained unclear. We have observed that 30-min incu- 
bation at 23 “C  in  the presence of mercaptoethanol causes 
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conversion of the 10 S receptor to 6.2 S. Neither sodium 
molybdate, cupric phenanthroline,  nor zinc  was able to effi- 
ciently reconstitute the 6 S receptor to 10 S, suggesting that 
under the experimental conditions tested, the conversion is 
irreversible. Although unlikely, it  cannot be ruled out that 
limited proteolysis might have occurred. The irreversible na- 
ture of the 10 to 6 S conversion contrasts with the reversible 
interconversion that exists between the 4.5, 6.2, and 8 S 
receptor forms (6) .  This equilibrium is influenced by divalent 
cations and requires the 4.5 S steroid binding portion of the 
receptor plus 8 S-PF (6). Attempts to generate the 10 S 
receptor using the partially purified components have been 
unsuccessful. One possibility that might explain the irrever- 
sibility of 10 S receptor complex dissociation is that once 
dissociated by reduction of disulfide bond(s),  a conformational 
change initiated by steroid binding might prohibit reassocia- 
tion,  thereby  assuring the transformed  state. Another possi- 
bility is that a chemical modification such  as phosphorylation 
inhibits 10 S reconstitution. The possible involvement of 
phosphorylation in  transformation of other steroid receptors 
has been reported (9, 41-43) but remains to be investigated 
for the androgen receptor. 
Previous reports of endogenous low molecular weight inhib- 
itors of steroid receptor transformation were based on obser- 
vations that dialysis or gel filtration chromatography caused 
increased nuclear binding of receptors (44,45). It is conceiv- 
able that zinc is  this small molecular weight, dialyzable inhib- 
itor that acts to inhibit receptor transformation by preventing 
dissociation of the 10 S complex. The effects of Znz+ on the 
androgen receptor are complex, since in previous studies, we 
observed that Zn2+ in  the presence of mercaptoethanol pro- 
motes binding of the 4.5 S androgen receptor to nuclei (31) 
and nuclear matrix in  the absence of 8 S-PF (19). Yet zinc 
enhances 4.5 S receptor binding to 8 S-PF (6) and, as shown 
in  this  study, stabilizes large forms of the receptor up to 10 S 
when the receptor has  not been exposed to mercaptoethanol. 
Zinc might therefore act  as an inhibitor of receptor transfor- 
mation in cytosol, as well as a promotor of transformed 
receptor binding in nuclei. Whether zinc is an integral part 
of the 10 S androgen receptor awaits further investigation. 
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